GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 90 filers reported holding GENERATION BIO CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,906,257 | -33.9% | 502,970 | -4.1% | 0.00% | – |
| Q2 2023 | $2,883,222 | +30.5% | 524,222 | +2.0% | 0.00% | – |
| Q1 2023 | $2,209,314 | +14.3% | 513,794 | +4.4% | 0.00% | – |
| Q4 2022 | $1,933,464 | -25.2% | 491,976 | +1.0% | 0.00% | – |
| Q3 2022 | $2,585,000 | +93.3% | 486,884 | +138.9% | 0.00% | – |
| Q2 2022 | $1,337,000 | -14.6% | 203,817 | -4.5% | 0.00% | – |
| Q1 2022 | $1,566,000 | -9.4% | 213,349 | -12.6% | 0.00% | – |
| Q4 2021 | $1,728,000 | -70.9% | 244,151 | +3.1% | 0.00% | -100.0% |
| Q3 2021 | $5,937,000 | -13.2% | 236,796 | -6.9% | 0.00% | 0.0% |
| Q2 2021 | $6,841,000 | +37905.6% | 254,308 | +40459.5% | 0.00% | – |
| Q1 2021 | $18,000 | -93.0% | 627 | -93.1% | 0.00% | – |
| Q4 2020 | $257,000 | +335.6% | 9,070 | +373.4% | 0.00% | – |
| Q3 2020 | $59,000 | – | 1,916 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |